Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis
Top Cited Papers
Open Access
- 5 April 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 12 (6) , 966-971
- https://doi.org/10.1002/lt.20761
Abstract
The objective of this study was to predict postoperative liver failure and morbidity after hepatectomy for hepatocellular carcinoma (HCC) with cirrhosis. The model for end-stage liver disease (MELD) score is currently accepted as a disease severity index of cirrhotic patients awaiting liver transplantation; however, its impact on prognosis after resection of HCC on cirrhosis has never been investigated. One hundred fifty-four cirrhotic patients resected in a tertiary care setting for HCC were retrospectively analyzed. For each patient, the MELD score was calculated and related to postoperative liver failure and complications (morbidity). Hospital stay and 1-year survival was also investigated. MELD accuracy in predicting postoperative liver failure and morbidity of cirrhotic patients was assessed using receiver operating characteristic (ROC) analysis. Eleven patients (7.1%) experienced postoperative liver failure leading to death or transplantation. ROC analysis identified cirrhotic patients with a MELD score equal to or above 11 at high risk for postoperative liver failure (area under the curve [AUC] = 0.92, 95% confidence interval [CI] = 0.87–0.96; sensitivity = 82%; specificity = 89%). Forty-six patients (29.9%) developed at least 1 postoperative complication: ROC analysis identified patients with a MELD score equal to or above 9 at major risk for postoperative complications (AUC = 0.85, 95% CI = 0.78–0.89; sensitivity = 87%; specificity = 63%). Cirrhotic patients with MELD score below 9 had no postoperative liver failure and low morbidity (8.1%). In conclusion, the MELD score can accurately predict postoperative liver failure and morbidity of cirrhotic patients referred for resection of HCC and should be used to select the best candidates for hepatectomy. Liver Transpl 12:966–971, 2006. © 2006 AASLD.Keywords
This publication has 25 references indexed in Scilit:
- Analysis of factors affecting outcome after hepatectomy of patients with liver cirrhosis and small hepatocellular carcinomaBritish Journal of Surgery, 2003
- Extended Hepatic Resection for Hepatocellular Carcinoma in Patients with Cirrhosis: Is It Justified?Annals of Surgery, 2002
- Preoperative Predictors of Survival After Resection of Small Hepatocellular CarcinomasAnnals of Surgery, 2002
- Improved Results of Liver Resection for Hepatocellular Carcinoma on Cirrhosis Give the Procedure Added ValueAnnals of Surgery, 2001
- The lidocaine (MEGX) test as an index of hepatic function: Its clinical usefulness in liver surgery☆☆☆Surgery, 2000
- Early Hepatocellular Carcinoma As An Entity With A High Rate of Surgical CureHepatology, 1998
- Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomyBritish Journal of Surgery, 1997
- Criteria for safe hepatic resectionThe American Journal of Surgery, 1995
- Resection of hepatocellular carcinomasGastroenterology, 1990
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973